Case Reports in Veterinary Medicine

Volume 2014 (2014), Article ID 603852, 4 pages

http://dx.doi.org/10.1155/2014/603852

Case Report

Leishmania sp. Amastigotes Identification in Canine Transmissible Venereal Tumor

Vinicius Soares Carreira,1,2 Heitor Flávio Ferrari,¹ Ingeborg Maria Langohr,³ Charles Mackenzie,⁴ Luiz Carlos Montezzo,⁵ Edson Taira,⁶ Lucile Maria Floeter-Winter,⁷ and Maria Cecília Rui Luvizotto¹

¹Departamento de Clínica, Cirurgia e Reprodução Animal (DCCRA), Laboratório de Patologia Animal, Universidade Estadual de São Paulo (UNESP), Campus Araçatuba, Rua Clóvis Pestana 793, 16050-680 Araçatuba, SP, Brazil

²Department of Environmental Health, University of Cincinnati, 3223 Eden Avenue, Kettering Laboratory, Cincinnati, OH 45267-0056, USA

³Department of Pathobiological Science, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive, Baton Rouge, LA 70803, USA

⁴Department of Pathobiology and Diagnostic Investigation (PDI), Veterinary Medical Center F Wing, 784 Wilson Road, Room F130, East Lansing, MI 48824-1314, USA

⁵Diagnostic Pathology Private Practice, Rua Treze de Maio 1671, 16901018 Andradina, SP, Brazil

⁶DCCRA, Hospital Veterinário, Universidade Estadual de São Paulo (UNESP), Campus Araçatuba, Rua Clovis Pestana 793, 6050-680 Araçatuba, SP, Brazil

⁷Instituto de Biociências, Cidade Universitária/Universidade de São Paulo, Rua do Matão Travessa 14 No. 321, 05508-090 São Paulo, SP, Brazil

Received 30 April 2014; Revised 9 July 2014; Accepted 16 July 2014; Published 24 August 2014

Academic Editor: Renato L. Santos

Copyright © 2014 Vinicius Soares Carreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Leishmaniasis is a vector-borne disease with Leishmania chagasi being the etiological agent of canine visceral leishmaniasis in South America. Canine venereal tumor is a transplantable round cell tumor of histiocytic origin which is mostly observed in sexually active male and female intact dogs. It has been shown that Leishmania amastigotes have higher tropism for the canine male genital tract tissues and venereal leishmaniasis transmission has been documented in dogs but, to date, a canine venereal tumor-dependent transmission route has not been fully demonstrated. In this report, a 10-year-old, mixed breed, intact female dog presented a vaginal venereal transmissible tumor but no other clinical abnormalities otherwise. Unexpectedly, tumor tissue imprint smears examination revealed Leishmania sp. amastigotes within infiltrating macrophages. In addition to the cytological direct identification, the protozoan was confirmed within the neoplastic tissue by means of immunohistochemistry and polymerase chain reaction. This report illustrates an asymptomatic Leishmania sp. infection that may have started on or from the canine venereal tumor tissue, the latter option further supporting previous evidence of such an alternative vector-independent route of transmission for canine visceral leishmaniasis in areas where these diseases coexist.

1. Introduction

Leishmaniasis is an anthropozoonotic disease with wide geographic distribution, affecting humans, dogs, and several wildlife species, and is caused by the obligate intracellular protozoa belonging to the genus Leishmania. Among Leishmania species, Leishmania chagasi and L. braziliensis are the documented species found in Araçatuba, northwest state of São Paulo, Brazil [1]. Depending on the infecting Leishmania species and the immunocompetence of the host, the infection can result in visceral, cutaneous, or mucocutaneous disease. Visceral leishmaniasis in dogs (CanVL) is associated with variable clinical manifestations ranging from unapparent subclinical infections to a systemic disease characterized by progressive weight loss, hepatosplenomegaly, lymphadenopathy, and a range of ocular and dermatological manifestations [2]. Canine transmissible venereal tumor (CTVT) is a unique neoplastic entity that is sexually transmissible and regarded as the oldest known mammalian somatic cell neoplasm in continuous propagation [3]. CTVT has worldwide distribution, with higher incidence in tropical areas, and has been mostly reported in dogs (Canis familiaris) and foxes (Vulpes sp.). Clinically, CTVT lesions are red to tan, friable, verrucous to multilobulated masses, predominantly affecting genital organs, and are usually ulcerated and inflamed [4]. Metastasis may occur, with lymphatic or visceral dissemination generally associated with underlying immunological impairment [5]. In addition, CTVT extragenital lesions, such as cutaneous, are relatively common and have been reported even in the absence of primary genital lesions [5, 6]. CTVT transmission occurs by means of direct neoplastic cell implantation, and successful CTVT implantation has been linked to an ineffective immune response. Conversely, an efficient postimplantation adaptive immune response is believed to be associated with the mechanism of natural regression that commonly occurs with this tumor [5]. CTVT and CanVL can overlap epidemiologically particularly in regard to their geographical distribution, as in the case presented herein. Leishmania sp. reportedly has tropism for the canine male genital tract [7] although the same was not observed in the female genital tract [8]. Venereal transmission via semen has been demonstrated [9]. However, it remains to be experimentally demonstrated whether Leishmania-laden CTVT cells can successfully transmit the protozoan to another host. In veterinary medicine, CanVL has been previously identified concurrently with canine transmissible venereal tumor as well as Leishmania sp. amastigotes within CTVT neoplastic cells per se [10–12]. Interestingly, in a recent retrospective study, 5 out of 19 dogs affected by both leishmaniasis and CTVT also had detectable amastigotes within the CTVT neoplastic tissue [12].

In regard to the synergistic nature of systemic parasitism and neoplasia, it has been proposed that concurrent diseases may occur secondary to the CanVL-driven immune impairment or, alternatively, neoplastic diseases could hamper the immune system, thus triggering the onset of clinical leishmaniasis in an already infected but asymptomatic dog [12, 13]. The coexistence in the same lesion of CTVT and Leishmania has been previously attributed to the systemic dissemination of the latter [10], where amastigote-laden macrophages get recruited into the CTVT tissue. It has been suggested that the histiocytic immunophenotype of CTVT [14] may play an active role in the parasitic invasion of the CTVT neoplastic cells [10]. Furthermore, the fact that Leishmania amastigotes can be identified within CTVT neoplastic cells supports the hypothesis of a monocyte/macrophage lineage histogenesis of this tumor [6]. Finally, it has been suggested that Leishmania amastigotes-laden neoplastic CTVT cells can represent an alternative mode of transmission of canine leishmaniasis in areas where these diseases coexist [11, 12, 15].

2. Case Report

A 10-year-old, mixed breed intact female dog was submitted to the Veterinary Teaching Hospital with a 3-month history of a 4.0 × 3.0 cm vaginal vestibule mass (Figure 1) without any other significant systemic clinical signs. Examination of tumor imprint smears revealed abundant typical CTVT cells admixed with degenerate neutrophils. Hematological findings were within normal limits. At the time of CTVT diagnosis, Leishmania sp. serology as performed by Lima et al. [16] was negative. Therefore, standard chemotherapy protocol using intravenous vincristine sulphate 0.5 mg/m² was administered once weekly. After the fourth chemotherapy session, and with a reminiscent 3.0 × 2.0 cm mass, additional cytology sampling and biopsy were performed. Cytology smears consisted predominantly of mature keratinized epithelial cells admixed with neutrophils, lymphocytes, and plasma cells, as well as moderate numbers of mixed-morphology bacteria. Few 2-3 μm oval Leishmania amastigotes with characteristic perinuclear rod-shaped kinetoplast could be observed within macrophages (Figure 2) as well as free in the smear. At this point, no remaining CTVT neoplastic cells could be identified cytologically. Histopathology findings consisted of extensive inflammatory infiltrate within the subepithelial vaginal stroma composed of lymphocytes and plasma cells, moderate amounts of neutrophils, and abundant macrophages, several of which were loaded with amastigote organisms (Figures 3 and 4), as well as rare reminiscent CTVT neoplastic cells within reactive newly formed collagen (fibrosis). Immunohistochemistry performed as described by Nogueira et al. [17] labeled myriads of Leishmania sp. amastigotes within the cytoplasm of histiocytoid cells (Figure 5), interpreted as macrophages, and dispersed through the neoplastic tissue. Furthermore, polymerase chain reaction (PCR) as performed by Moreira et al. [18] confirmed the presence of Leishmania sp. DNA in the tissue. Apart from the vaginal mass, the dog was healthy, presenting no overt clinical signs of canine leishmaniasis. This dog continued to have negative serology for Leishmania and was devoid of clinical disease up to one year following the last biopsy of the reminiscent CTVT lesion, but after this time it was lost to follow-up.

Figure 1: Dog. Vaginal vestibule, red verrucous, and lobulated mass protruding from the vagina.

Figure 2: Dog. Photomicrograph of cytology imprint from the vaginal mass with a histiocyte-like cell with three intracytoplasmic protozoa amastigotes (arrow) (Diff-Quick, 100x).

Figure 3: Dog. Photomicrograph of vaginal mucosa with the subepithelial stroma effaced by canine transmissible venereal tumor cells, mixed with macrophages and with a mild diffuse lymphoplasmacytic infiltrate (H&E, 20x).

Figure 4: Dog. Photomicrograph of vaginal mucosa and canine venereal tumor cells (red arrow); accompanying inflammatory infiltrate within the subepithelial stroma was composed of lymphocytes, plasma cells, few neutrophils, and amastigote-laden macrophages (black arrow) which are shown in higher magnification in the inset (H&E, 40x and 63x).

Figure 5: Dog. Photomicrograph of vaginal mucosa and immunohistochemistry staining highlighting Leishmania sp. amastigotes (DAB hematoxylin-counterstained, 40x and 63x).

3. Discussion

Low cost and near 100% specificity make cytology the most accessible method for diagnosing CTVT and canine leishmaniasis (CanVL) provided that the examiner is familiar with the unique cellular morphology of the CTVT cells and the identification of Leishmania amastigotes. Identification of Leishmania amastigotes within hematoxylin and eosin-stained tissue sections is challenging and depends on the affected tissue, stage of infection, severity of the secondary inflammatory response, and number of organisms [18]. However, as in this case, such diagnostic challenges may be circumvented by using ancillary techniques such as intissue antibody-based identification of amastigotes via immunohistochemistry [18, 19]. CTVT diagnosis is routinely done based on its characteristic cytological findings. Tumors that receive chemotherapy and have concurrent regression response are histologically characterized by decreased neoplastic cell population, with predominantly degenerate remnant cells amidst extensive stromal remodeling and lymphoplasmacytic inflammatory infiltrate [20]. These changes are in agreement with our findings of absent typical CTVT cells in the second cytology sample as well as the predominantly inflammatory and fibrosing morphology of the biopsy sample. Furthermore, the occurrence of Leishmania infection within the tissue possibly resulted in added granulation tissue formation that grossly resembled a neoplasm that was responding to chemotherapy unsatisfactorily.

The coexistence of CTVT and leishmaniasis in this dog is corroborated by the endemic nature of both diseases in Araçatuba (northwest state of São Paulo, Brazil), particularly among roaming dogs [1]. This dog had CTVT genital lesions which could have provided a feeding site to the female sand fly vector; the fact that Leishmania amastigotes could have transplanted with CTVT cells to this new host, thereby circumventing the vector in the classic transmission route of canine leishmaniasis, is also a tempting possibility [12, 15].

4. Conclusions

This report illustrates an asymptomatic Leishmania sp. infection concurrent with a transmissible venereal tumor. We speculate that the Leishmania sp. infection may have started on or from the CTVT, the latter option further supporting previous evidence of such an alternative vector-independent route of transmission for CanVL in areas where these diseases coexist. While it was not possible to determine whether this dog had been previously infected with Leishmania prior to CTVT, negative serology for Leishmania at the time of CTVT diagnosis could indicate an early stage of infection favoring the preexistence of the CTVT. Nonetheless, a negative serology result due to a CanVL-driven impaired adaptive immune system cannot be discarded. Experimental evidence of amastigotes uptake by and viability within CTVT cells, as well as amastigote-laden CTVT cells transmission capabilities, is critically lacking. Thoroughly screening CTVT-affected dogs for leishmaniasis in areas where these diseases coexist is highly warranted. The present case underscores the diagnostic challenges, complex nature, and the potential epidemiological consequences of overlapping infectious diseases.

Conflict of Interests

The authors declared no potential conflict of interests with respect to the research, authorship, and/or publication of this paper.

References

C. C. Casanova, L. A. Rodas, and E. A. Galati, “Atualização da distribuição geográfica e primeiro encontro de Lutzomyia longipalpis em área urbana no Estado de São Paulo, Brasil,” Revista de Saúde Pública, vol. 31, pp. 632–633, 1997.

P. Ciaramella and M. Corona, “Canine leishmaniasis: clinical and diagnostic aspects,” Compendium on Continuing Education for the Practicing Veterinarian, vol. 25, no. 5, pp. 358–368, 2003.

C. Murgia, J. K. Pritchard, S. Y. Kim, A. Fassati, and R. A. Weiss, “Clonal origin and evolution of a transmissible cancer,” Cell, vol. 126, no. 3, pp. 477–487, 2006.

M. H. Goldschmidt and M. J. Hendrick, “Tumors of the skin and soft tissue,” in Tumors in Domestic Animals, D. J. Meuten, Ed., pp. 115–117, Iowa State Press, Ames, Iowa, USA, 2002.

U. Das and A. K. Das, “Review of canine transmissible venereal sarcoma,” Veterinary Research Communications, vol. 24, no. 8, pp. 545–556, 2000.

F. Albanese, A. Poli, F. Millanta, and F. Abramo, “Primary cutaneous extragenital canine transmissible venereal tumour with Leishmania-laden neoplastic cells: a further suggestion of histiocytic origin?” Veterinary Dermatology, vol. 13, no. 5, pp. 243–246, 2002.

S. A. Diniz, M. S. Melo, A. M. Borges et al., “Genital lesions associated with visceral leishmaniasis and shedding of Leishmania sp. in the semen of naturally infected dogs,” Veterinary Pathology, vol. 42, no. 5, pp. 650–658, 2005.

F. L. Silva, A. A. M. Rodrigues, I. O. P. Rego et al., “Genital lesions and distribution of amastigotes in bitches naturally infected with Leishmania chagasi,” Veterinary Parasitology, vol. 151, no. 1, pp. 86–90, 2008.

F. L. Silva, R. G. Oliveira, T. M. A. Silva, M. N. Xavier, E. F. Nascimento, and R. L. Santos, “Venereal transmission of canine visceral leishmaniasis,” Veterinary Parasitology, vol. 160, no. 1-2, pp. 55–59, 2009.

G. Catone, G. Marino, G. Poglayen, M. Gramiccia, A. Ludovisi, and A. Zanghì, “Canine transmissible venereal tumour parasitized by Leishmania infantum,” Veterinary Research Communications, vol. 27, no. 7, pp. 549–553, 2003.

K. Kegler, A. Habierski, K. Hahn, S. P. Amarilla, F. Seehusen, and W. Baumgärtner, “Vaginal canine transmissible venereal tumour associated with intra-tumoural leishmania spp. amastigotes in an asymptomatic female dog,” Journal of Comparative Pathology, vol. 149, no. 2-3, pp. 156–161, 2013.

G. Marino, G. Gaglio, and A. Zanghì, “Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs,” Journal of Small Animal Practice, vol. 53, no. 6, pp. 323–327, 2012.

L. Ferrer, “Simultaneous presentation of leishmaniosis and other infectious diseases: clinical approach and mechanisms,” in Proceedings of the International Congress on Canine Leishmaniasis, vol. 38, pp. 37–38, Naples, Italy, 2004.

E. Mozos, A. Méndez, J. C. Gómez-Villamandos, J. Martín De Las Mulas, and J. Pérez, “Immunohistochemical characterization of canine transmissible venereal tumor,” Veterinary Pathology, vol. 33, no. 3, pp. 257–263, May 1996.

E. Levy, M. E. Mylonakis, M. N. Saridomichelakis, Z. S. Polizopoulou, V. Psychogios, and A. F. Koutinas, “Nasal and oral masses in a dog,” Veterinary Clinical Pathology, vol. 35, no. 1, pp. 115–118, 2006.

V. M. F. Lima, M. E. Gonçalves, F. A. Ikeda, M. C. R. Luvizotto, and M. M. Feitosa, “Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis,” Brazilian Journal of Medical and Biological Research, vol. 36, no. 4, pp. 485–489, 2003.

F. S. Nogueira, M. A. B. Moreira, G. P. Borja-Cabrera et al., “Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs,” Vaccine, vol. 23, no. 40, pp. 4805–4810, 2005.

M. A. B. Moreira, M. C. R. Luvizotto, J. F. Garcia, C. E. P. Corbett, and M. D. Laurenti, “Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs,” Veterinary Parasitology, vol. 145, no. 3-4, pp. 245–252, 2007.

W. L. Tafuri, R. D. L. Santos, R. M. E. Arantes, R. Gonçalves, M. N. De Melo, and M. S. M. Michalick, “An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues,” Journal of Immunological Methods, vol. 292, no. 1-2, pp. 17–23, 2004.

C. M. Gonzalez, S. M. Griffey, D. K. Naydan et al., “Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy,” Journal of Comparative Pathology, vol. 122, no. 4, pp. 241–248, 2000.